A role for lymphotoxin β receptor in host defense against Mycobacterium bovis BCG infection

European Journal of Immunology

Volumn 29, Issue 12, 1999, Pages 4002-4010

  Lucas, Rudolf ^a   Tacchini Cottier, Fabienne ^b,f   Guler, Reto ^b   Vesin, Dominique ^b   Jemelin, Stephane ^b   Olleros, Maria L ^b   Marchal, Gilles ^c   Browning, Jeffrey L ^d   Vassalli, Pierre ^b   Garcia, Irene ^b,e  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b University Medical Center   (Switzerland)

^c INSTITUT PASTEUR   (France)

^d BIOGEN   (United States)

^e CMU   (Switzerland)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Bacillus Calmette Guerin; Granuloma; Lymphotoxin receptor; Spleen

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G3; INTERLEUKIN 4; LYMPHOTOXIN; NITRIC OXIDE SYNTHASE; RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS; CONTROLLED STUDY; ENZYME ACTIVITY; GRANULOMA; HOST RESISTANCE; MACROPHAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; GENE EXPRESSION REGULATION; IMMUNITY; LYMPHOTOXIN BETA RECEPTOR; LYMPHOTOXIN-ALPHA; LYMPHOTOXIN-BETA; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MYCOBACTERIUM BOVIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUBERCULOSIS;

EID: 0032709799     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199912)29:12<4002::AID-IMMU4002>3.0.CO;2-S     Document Type: Article

References (40)

1. Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A. and Stewart, T. A., Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 1993. 259: 1739-1742.
2. Denis, M., Interferon-gamma treated murine macrophages inhibit growth of tubercle bacilli via generation of reactive nitrogen intermediates. Cell. Immunol. 1991. 132: 150-157.
3. Gordon, S., Keshav, S. and Stein, M., BCG-induced granuloma formation in murine tissues. Immunobiology 1994. 191: 369-377.
4. MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K. and Nathan, C. F., Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 1997. 94: 5243-5248.
5. Kindler, V., Sappino, A. P., Grau, G. E., Piguet, P. F. and Vassalli, P., The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989. 56: 731-740.
6. Senaldi, G., Yin, S., Shaklee, C. L., Piguet, P. F., Mak, T. W. and Ulich, T. R., Corynebacterium parvum- and Mycobacterium bovis Bacillus Calmette-Guérin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J. Immunol. 1996. 157: 5022-5026.
7. Adams, L. B., Mason, C. M., Kolls, J. K., Scollard, D., Kraehenbuhl, J. L. and Nelson, S., Exacerbation of acute and chronic murine tuberculosis by administration of tumor necrosis factor receptor-expressing adenovirus. J. Infect. Dis. 1995. 171: 400-405.
8. Garcia, I., Miyazaki, Y., Marchal, G., Lesslauer, W. and Vassalli, P., High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections; synergistic action of TNF and IFN-γ in the differentiation of protective granulomas. Eur. J. Immunol. 1997. 27: 3182-3190.
9. Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schreiber, R., Mak, T. W. and Bloom, B. R., Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995. 2: 561-572.
10. Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R. M. and Aguet, M., Immune response in mice that lack the interferon-gamma receptor. Science 1993. 259: 1742-1745.
11. Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G. and Orme, I. M., Disseminated tuberculosis in interferon-gamma gene-disrupted mice. J. Exp. Med. 1993. 178: 2243-2247.
12. Kamijo, R., Le, J., Shapiro, D., Havell, E. A., Huang, S., Aguet, M., Bosland, M. and Vilcek, J., Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 1993. 178: 1435-1440.
13. Kamijo, R., Shapiro, D., Le, J., Huang, S., Aguet, M. and Vilcek, J., Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon-gamma receptor. Proc. Natl. Acad. Sci. USA 1993. 90: 6626-6630.
14. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A. and Bloom, B. R., An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 1993. 178: 2249-2254.
15. Flesch, I. E. A., Hess, J. H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H. and Kaufmann, S. H. E., Early interleukin 12 production by macrophages in response to Mycobacterial infection depends on Interferon γ and tumor necrosis factor α. J. Exp. Med. 1995. 181: 1615-1621.
16. Sugawara, I., Yamada, H., Kaneko, H., Mizuno, S., Takeda, K. and Akira, S., Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene disrupted mice. Infect. Immun. 1999. 67: 2585-2589.
17. Cooper, A. M., Magram, J., Ferrante, J. and Orme, I. M., Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 1997. 186: 39-45.
18. Browning, J. L., Ngam-ek, A., Lawton, P., De Marinis, J., Tizard, R., Chow, E. P., Hession, C., O'Brine-Greco B., Foley, S. F. and Ware, C. F., Lymphotoxin-beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993. 72: 847-856.
19. Browning, J. L., Dougas, I., Ngam-ek, E. A., Bourdon, P. R., Ehrenfels, B. N., Miatkowski, K., Zafari, M., Yampaglia, A. M., Lawton, P., Meier, W., Benjamin, C. P. and Hession, C., Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. J. Immunol. 1995. 154: 33-46.
20. Crowe, P. D., VanArsdale, T. L., Walter, B. N., Ware, C. F., Hession, C., Ehrenfels, B., Browning, J. L., Din, W. S., Goodwin, R. G. and Smith, C. A., A lymphotoxin-beta-specific receptor. Science 1994. 264: 707-710.
21. Mauri, D. N., Ebner, R., Montgomery, R. I., Kochel, K. D., Cheung, T. C., Yu, G. L., Ruben, S., Murphy, M., Eisenberg, R. J., Cohen, G. H., Spear, P. G. and Ware, C. F., LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 1998. 8: 21-30.
22. Ettinger, R., Browning, J. L., Michie, S. A., van Ewijk, W. and McDevitt, H. O., Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. Proc. Natl. Acad. Sci. USA 1996. 93: 13102-13107.
23. Chaplin, D. D. and Fu, Y., Cytokine regulation of secondary lymphoid organ development. Curr. Opin. Immunol. 1998. 10: 289-297.
24. De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P. and Strauss-Schoenberger, J., Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994. 264: 703-707.
25. Koni, P., Sacca, R., Lawton, P., Browning, J. L., Ruddle, N. H. and Flavell, R. A., Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 1997. 6: 491-500.
26. Rennert, P. D., James, D., Mackay, F., Browning, J. L. and Hochman, P. S., Lymph node genesis is induced by signaling throuth the lymphotoxin beta receptor. Immunity 1998. 9: 71-79.
27. Mackay, F., Majeau, G. R., Lawton, P., Hochmann, P. S. and Browning, J. L., Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 1997. 27: 2033-2042.
28. Futterer, A., Mink, K., Luz, A., Kosco-Vilbois, M. H. and Pfeffer, K., The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998. 9: 59-70.
29. Mackay, F. and Browning, J. L., Turning off follicular dendritic cells. Nature 1998. 395: 26-27.
30. Gonzalez, M., Mackay, F., Browning, J. L., Kosco-Vilbois, M. H. and Noelle, R. J., The sequential role of lymphotoxin and B cells in the development of splenic follicles. J. Exp. Med. 1998. 187: 997-1007.
31. Ragosti, N., Labrousse, V. and de Sousa, J. P., Mycobacterial growth and ultrastructure in mouse L-129 fibroblasts and bone marrow-derived macrophages: evidence that infected fibroblasts secrete mediators capable of modulating bacterial growth in macrophages. Curr. Microbiol. 1992. 25: 203-213.
32. Tanaka, S., Sato, M., Taniguchi, T. and Yokomizo, Y., Relationship of acid phosphatase activity to ultrastructural features in mice inoculated with Mycobacterium paratuberculosis. J. Comp. Pathol. 1996. 114: 81-91.
33. Bredt, D. S. and Snyder, S. H., Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 1989. 86: 9030-9033.
34. Trinchieri, G., Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today 1993. 14: 335-338.
35. Ladel, C. H., Szalay, G., Riedel, D. and Kaufmann, S. H., Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages. Infect. Immun. 1997. 65: 1936-1938.
36. Chan, J., Xing, Y., Magliozzo, R. S. and Bloom, B. R., Killing of virulent Mycobacterium tuberculosis by reactive intermediates produced by activated murine macrophages. J. Exp. Med. 1992. 175: 1111-1122.
37. Ehlers, S., Benini, J., Kutsch, S., Endres, R., Rietschel, E. T. and Pfeffer, K., Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect. Immun. 1999. 67: 3571-3579.
38. Garcia, I., Miyazaki, Y., Araki, K., Araki, M., Lucas, R., Grau, G. E., Milon, G., Belkaid, Y., Montixi, C., Lesslauer, W. and Vassalli, P., Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 1995. 25: 2401-2407.
39. Force, W. R., Walter, B. N., Hession, C., Tizard, R., Kozak, C. A., Browning, J. L. and Ware, C. F., Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression. J. Immunol. 1995. 155: 5280-5288.
40. Nakane, A., Numata, A. and Minagawa, T., Endogenous tumor necrosis factor, interleukin-6, and gamma interferon levels during Listeria monocytogenes infection in mice. Infect. Immun. 1992. 60: 523-528.